BloodHorse Dec 16 2015

1. 12/21/2015 Tracks, Regulators Aim for Improved Testing | BloodHorse.com
http://www.bloodhorse.com/horse­racing/articles/96597/tracks­regulators­aim­for­improved­testing/print 1/2
Tracks, Regulators Aim for Improved Testing
by Frank Angst
Date Posted: 12/16/2015 5:21:36 PM
In a story that stunned attendees at the Global Symposium on Racing and Gaming Dec. 8, Kentucky Horse Racing
Commission equine medical director Mary Scollay told a story of a misunderstanding between a lab and state
regulator that compromised drug testing in a state (not Kentucky).
"The contract required a three­day turnaround time of samples but the lab director interpreted that to mean if work
wasn't completed by the end of three days, he would report the samples as passed. And he did," Scollay said. "I
assure that is not what the commission intended when they wrote their contract."
The anecdote served as a reminder of the importance to make sure contracts properly outline the work and level of
work state regulators require from their contracted testing lab. It's become a point of emphasis in the industry.
NTRA Safety and Integrity Alliance executive director Steve Koch said his group's current code of standards
requiring regulators send samples to labs accredited by the Racing Medication and Testing Consortium has been
updated to call on regulators to also make sure testing contracts call for the proper level of examination.
Koch said the 23 alliance racetracks, which account for 90% of graded stakes in the U.S., will be asked to work with
their state regulators to make sure testing programs are at the proper standard. Those standards include reliance on
LC­MS instruments in testing and ending any pooling of samples.
"So the point of putting this into the code of standards is so that the racetracks start asking those questions, get
engaged; and hopefully the regulators will engage back," Koch said. "That way everybody can be very comfortable.
We're all paying into this. Ultimately it's coming out of horse racing to pay for these things, one way or another,
whether it's directly from the track, through levies, or whatever it might be.
"The point of this is to actually drive that engagement across the industry. It's everyone—the horsemen, the
racetrack operators, and the regulators should be involved in this process."
Scollay noted that quality testing strengthens the racing product.
"A racetrack operator should be aware that poor drug testing impacts the quality and credibility of the product you're
promoting," Scollay said. "Bad drug testing is going to cost you money at the bottom­line level."
RMTC executive director Dionne Benson noted that the group has prepared a document to help states make sure
they call for a proper level of testing when they formulate contracts with labs. Benson said in the nine months the
document has been in place, several states have already used it to install new agreements on testing.
Benson noted the document was produced after the RMTC examined contracts provided by several states with their
testing labs. That examination certainly revealed a need.
"What we did was review a number of commission contracts. A number of jurisdictions provided them and we were
able to review. Some of the information was very interesting; there are a number of jurisdictions that are doing great
work. By contrast there are some jurisdictions that don't even have a written contract," Benson said. "I'm not sure
how you would specify what the requirements are if you're not writing something down. ... There was variation in
testing, preparation of samples, and cost of testing."
Use of accredited labs by all racing jurisdictions is one of the pillars of the National Uniform Medication Program,
which aims to bring uniformity to medication rules, testing and penalties, state by state. Currently 12 of the 14 labs
being used by racetracks in the U.S. are accredited by the RMTC.
Koch noted that accreditation by the RMTC only means that labs are capable of doing proper testing work. But state

2. 12/21/2015 Tracks, Regulators Aim for Improved Testing | BloodHorse.com
http://www.bloodhorse.com/horse­racing/articles/96597/tracks­regulators­aim­for­improved­testing/print 2/2
contracts have to ensure the proper level of testing is requested of those labs.
"It is your regulator's signed operating agreement with those labs that dictates how the laboratory actually executes
on your drug­testing program," Koch said, speaking to racetracks. "Failures we've seen recently sometimes relate to
the pitfalls of these misaligned laboratory service agreements."
Benson said the RMTC's 40­page document on proper request­for­proposals for drug testing agreements with labs
will help states ensure their contracts call for the proper level of testing.
"The RMTC board, early on in this exercise, recognized that there was a gap between what the RMTC accreditation
standards required and what was necessarily being required by the jurisdiction contracts," Benson said. "So to
ensure that we have the laboratories able to perform at a high level, and that they are performing at a high level, we
felt it was necessary to take this next step. The key to this is ensuring that the laboratory contracts with each
commission effectively require their best testing."
The alliance and the RMTC want racing to move to instrument testing (LC­MS), which is capable of searching for a
wide spectrum of substances, as opposed to ELISA tests, which provide more specific searches.
The standards also call for a move away from pooling of samples where labs run preliminary tests on several
samples at one time. If a positive is found, all of the samples are tested further but if no positive is found, all of the
samples are passed. Scollay noted that when such pooling is done, concentration levels of any potential substance
are reduced, making them more difficult to pick up.
Benson acknowledged that some states likely will have to spend more money, although some savings could be
reached by testing fewer samples. She said testing fewer samples at a higher level is preferred to testing many at a
lower level.
"To be frank, this will likely represent an increase in cost for some jurisdictions, especially if you intend to do the
same number of samples," Benson said.
Scollay encouraged regulators and tracks to make sure their lab contract calls for the proper level of testing.
"My take home message is, "Know what you want from your drug­testing program.' If you're unsure what you want,
the model RFP is a good place to start because in addition to telling you the things that you should require, it
explains why you should require them so you can have some confidence when you go to your procurement agency
saying, 'We have to do it this way' it's important,'" Scollay said. "Require the service provider to do the work. Make
sure your contract doesn't offer the opportunity for somebody to cut a corner."
Copyright © 2015 The Blood­Horse, Inc. All Rights Reserved.
SUBSCRIBE to The Blood­Horse magazine TODAY!